HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients.

Abstract
Breast cancer is associated with alterations in a number of growth factor and hormone-regulated signaling pathways. Mouse models of metastatic breast cancer typically feature mutated oncoproteins that activate PI3K, Stat3, and Ras signaling, but the individual and combined roles of these pathways in breast cancer progression are poorly understood. In this study, we examined the relationship between oncogenic pathway activation and breast cancer subtype by analyzing mouse mammary tumor formation in which each pathway was activated singly or pairwise. All three oncogenes showed cooperation during primary tumor formation, but efficient dissemination was only dependent on Ras. In addition, transcriptional profiling demonstrated that Ras induced adenocarcinomas with molecular characteristics related to human basal-like and HER2(+) tumors. In contrast, Ras combined with PIK3CA(H1047R), an oncogenic mutant linked to ERα(+)/luminal breast cancer in humans, induced metastatic luminal B-like tumors. Consistent with these data, elevated Ras signaling was associated with basal-like and HER2(+) subtype tumors in humans and showed a statistically significant negative association with estrogen receptor (ER) signaling across all breast cancer. Despite this, there are luminal tumors with elevated Ras signaling. Importantly, when considered as a continuous variable, Ras pathway activation was strongly linked to reduced survival of patients with ERα(+) disease independent of PI3K or Stat3 activation. Therefore, our studies suggest that Ras activation is a key determinant for dissemination and poor prognosis of ERα(+)/luminal breast cancer in humans, and hormone therapy supplemented with Ras-targeting agents may be beneficial for treating this aggressive subtype.
AuthorsKatherine L Wright, Jessica R Adams, Jeff C Liu, Amanda J Loch, Ruth G Wong, Christine E B Jo, Lauren A Beck, Divya R Santhanam, Laura Weiss, Xue Mei, Timothy F Lane, Sergei B Koralov, Susan J Done, James R Woodgett, Eldad Zacksenhaus, Pingzhao Hu, Sean E Egan
JournalCancer research (Cancer Res) Vol. 75 Issue 22 Pg. 4960-72 (Nov 15 2015) ISSN: 1538-7445 [Electronic] United States
PMID26400062 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2015 American Association for Cancer Research.
Chemical References
  • ras Proteins
Topics
  • Animals
  • Breast Neoplasms (metabolism, mortality, pathology)
  • Disease-Free Survival
  • Female
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Mice
  • Neoplasm Invasiveness (pathology)
  • Neoplasm Recurrence, Local (metabolism, pathology)
  • Oligonucleotide Array Sequence Analysis
  • Signal Transduction (physiology)
  • ras Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: